Shareholders of Medytox Solutions, Inc. (MMMS) and CollabRX, Inc. (CLRX) Approve Merger

Newly Combined Company Expected to Trade on November 3, 2015 as Rennova Health, Inc. (RNVA)


WEST PALM BEACH, FL--(Marketwired - Oct 30, 2015) - Medytox Solutions, Inc. ("Medytox") (OTCQB: MMMS), which owns and operates a diverse family of healthcare companies, including five clinical laboratories throughout the U.S., announced today that the shareholders of Medytox and CollabRx, Inc. have approved the proposed merger between Medytox and CollabRx.

Meydtox's board and management expect the closing of the merger, which is conditioned upon the satisfaction or waiver of certain closing conditions, to be completed on Monday, November 2, 2015. Assuming completion of the transaction, the combined company will be known as Rennova Health, Inc. and trade under the symbol "RNVA" beginning at market open on November 3, 2015.

About Medytox Solutions, Inc.

Medytox Solutions, Inc. (OTCQB: MMMS) is a holding company that owns and operates businesses in the medical services sector. Medytox is a new generation healthcare enterprise that delivers a single source for integrated solutions. Medytox applies its innovative approach through an outstanding suite of IT & software solutions, revenue cycle management and financial services, combined with a range of diagnostic testing and other ancillary services for the healthcare sector. Its principal line of business is clinical laboratory blood and urine testing services, with a particular emphasis in the provision of urine drug toxicology testing to physicians, clinics and rehabilitation facilities in the United States. More information may be obtained at http://www.medytoxsolutionsinc.com.

Safe Harbor Statement
This press release contains certain forward-looking information about Medytox Solutions, Inc. that is intended to be covered by the safe harbor for "forward-looking statements" provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. Words such as "guidance", "expect", "will", "may", "anticipate", "plan", "estimate", "project", "intend", "should", "can", "likely", "could", and similar expressions are intended to identify forward looking statements. These statements include statements about our plans, strategies and prospects. Forward-looking statements are not guarantees of performance. These statements are based upon the current beliefs and expectations of our management and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot assure you that the expectations will prove to be correct. Important factors that could cause our actual results or performance to differ materially from the forward-looking statements include those set forth in the "Risk Factors" section of our most recent annual report on Form 10-K and in our other filings with the Securities and Exchange Commission, which filings are available on www.sec.gov. You should not place undue reliance on these forward-looking statements, which speak only as of the date such statements are made. Except to the extent required by applicable law or regulation, we undertake no obligation to update or publish revised forward-looking statements to reflect events or circumstances after such date or to reflect the occurrence of unanticipated events.

Media inquiries may be directed to Meieli Sawyer at msawyer@weinbachgroup.com.

Contact Information:

Media Contact:
Meieli Sawyer
(305) 668-0070